Total Payments
$62,181
2024 Payments
$84.88
Companies
13
Transactions
69
Medicare Patients
2,713
Medicare Billing
$432,507
Payment Breakdown by Category
Other$39,311 (63.2%)
Travel$13,983 (22.5%)
Consulting$7,700 (12.4%)
Food & Beverage$1,175 (1.9%)
Education$11.92 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $39,311 | 11 | 63.2% |
| Travel and Lodging | $13,983 | 23 | 22.5% |
| Consulting Fee | $7,700 | 11 | 12.4% |
| Food and Beverage | $1,175 | 23 | 1.9% |
| Education | $11.92 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $61,271 | 51 | $0 (2022) |
| Celgene Corporation | $300.00 | 1 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $132.09 | 2 | $0 (2017) |
| Genentech USA, Inc. | $127.93 | 4 | $0 (2017) |
| Merck Sharp & Dohme Corporation | $120.83 | 1 | $0 (2017) |
| Dendreon Pharmaceuticals LLC | $90.60 | 2 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $29.90 | 1 | $0 (2024) |
| Daiichi Sankyo Inc. | $29.29 | 2 | $0 (2024) |
| Eisai Inc. | $25.69 | 1 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $15.12 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $84.88 | 4 | AstraZeneca Pharmaceuticals LP ($29.90) |
| 2022 | $600.00 | 2 | Celgene Corporation ($300.00) |
| 2021 | $11.92 | 1 | Gilead Sciences, Inc. ($11.92) |
| 2020 | $250.00 | 1 | E.R. Squibb & Sons, L.L.C. ($250.00) |
| 2019 | $5,151 | 5 | E.R. Squibb & Sons, L.L.C. ($5,060) |
| 2018 | $14,605 | 12 | E.R. Squibb & Sons, L.L.C. ($14,605) |
| 2017 | $41,479 | 44 | E.R. Squibb & Sons, L.L.C. ($41,057) |
All Payment Transactions
69 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: ONCOLOGY | ||||||
| 10/17/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $25.69 | General |
| Category: Oncology | ||||||
| 10/08/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $29.90 | General |
| 09/12/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: ONCOLOGY | ||||||
| 04/27/2022 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $300.00 | General |
| 04/27/2022 | Celgene Corporation | — | Consulting Fee | Cash or cash equivalent | $300.00 | General |
| 06/01/2021 | Gilead Sciences, Inc. | — | Education | In-kind items and services | $11.92 | General |
| 02/12/2020 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $250.00 | General |
| 12/27/2019 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,310.00 | General |
| Category: Oncology | ||||||
| 10/08/2019 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Consulting Fee | Cash or cash equivalent | $500.00 | General |
| Category: Oncology | ||||||
| 05/01/2019 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $250.00 | General |
| 03/13/2019 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $33.82 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 02/07/2019 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $56.78 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 05/10/2018 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Consulting Fee | Cash or cash equivalent | $500.00 | General |
| Category: Oncology | ||||||
| 04/27/2018 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,310.00 | General |
| Category: Oncology | ||||||
| 04/27/2018 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,230.00 | General |
| Category: Oncology | ||||||
| 04/27/2018 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,585.00 | General |
| Category: Oncology | ||||||
| 04/19/2018 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Travel and Lodging | Cash or cash equivalent | $929.04 | General |
| Category: Oncology | ||||||
| 04/19/2018 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Travel and Lodging | Cash or cash equivalent | $757.19 | General |
| Category: Oncology | ||||||
| 04/19/2018 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Travel and Lodging | Cash or cash equivalent | $746.70 | General |
| Category: Oncology | ||||||
| 04/19/2018 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Travel and Lodging | Cash or cash equivalent | $726.91 | General |
| Category: Oncology | ||||||
| 04/19/2018 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Travel and Lodging | Cash or cash equivalent | $183.15 | General |
| Category: Oncology | ||||||
| 04/19/2018 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $114.71 | General |
| Category: Oncology | ||||||
| 04/19/2018 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $22.01 | General |
| Category: Oncology | ||||||
| 01/12/2018 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Consulting Fee | Cash or cash equivalent | $500.00 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 643 | 1,146 | $426,705 | $113,870 |
| 2022 | 10 | 727 | 1,366 | $288,255 | $117,179 |
| 2021 | 11 | 680 | 1,374 | $239,642 | $107,699 |
| 2020 | 9 | 663 | 1,205 | $251,296 | $93,759 |
Total Patients
2,713
Total Services
5,091
Medicare Billing
$432,507
Procedure Codes
36
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 183 | 403 | $97,200 | $45,879 | 47.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 203 | 332 | $68,300 | $25,190 | 36.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 75 | 84 | $170,772 | $11,792 | 6.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 77 | 77 | $30,492 | $11,169 | 36.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 55 | 152 | $25,840 | $10,096 | 39.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 50 | 98 | $34,101 | $9,745 | 28.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 244 | 556 | $96,590 | $41,608 | 43.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 126 | 254 | $60,312 | $30,935 | 51.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 74 | 74 | $27,708 | $11,186 | 40.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 80 | 186 | $29,316 | $11,103 | 37.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 28 | 56 | $12,672 | $4,785 | 37.8% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 34 | 37 | $12,115 | $4,237 | 35.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 21 | 23 | $27,041 | $3,804 | 14.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 56 | 62 | $6,940 | $3,439 | 49.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 28 | 28 | $7,974 | $3,098 | 38.9% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 36 | 90 | $7,587 | $2,983 | 39.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 223 | 702 | $117,936 | $58,134 | 49.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 71 | 157 | $24,178 | $9,472 | 39.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 127 | 173 | $19,248 | $8,777 | 45.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 38 | 51 | $12,036 | $6,338 | 52.7% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 41 | 41 | $11,972 | $4,703 | 39.3% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 27 | 27 | $9,720 | $4,113 | 42.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 38 | 38 | $10,488 | $4,103 | 39.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 26 | 46 | $10,120 | $3,983 | 39.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 22 | 22 | $9,460 | $3,699 | 39.1% |
About Dr. Stephen Patterson, MD
Dr. Stephen Patterson, MD is a Medical Oncology healthcare provider based in Palm Springs, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1194748905.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Patterson, MD has received a total of $62,181 in payments from pharmaceutical and medical device companies, with $84.88 received in 2024. These payments were reported across 69 transactions from 13 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($39,311).
As a Medicare-enrolled provider, Patterson has provided services to 2,713 Medicare beneficiaries, totaling 5,091 services with total Medicare billing of $432,507. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Ad
Practice Information
- Specialty Medical Oncology
- Location Palm Springs, FL
- Active Since 07/25/2006
- Last Updated 01/09/2025
- Taxonomy Code 207RX0202X
- Entity Type Individual
- NPI Number 1194748905
Products in Payments
- OPDIVO (Biological) $60,471
- KEYTRUDA (Biological) $120.83
- KISQALI (Drug) $109.77
- Perjeta (Biological) $99.33
- PROVENGE (Drug) $90.60
- DARZALEX (Biological) $29.64
- Enhertu (Drug) $29.29
- Lenvima (Drug) $25.69
- TASIGNA (Drug) $22.32
- Zelboraf (Biological) $17.83
- Nexavar (Drug) $12.26
- Herceptin (Biological) $10.77
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Medical Oncology Doctors in Palm Springs
Dr. Sujal Shah, Md, MD
Medical Oncology — Payments: $11,808
Medical Oncology $11,808
Dr. Adam Kotkiewicz, D.o, D.O
Medical Oncology — Payments: $3,051
Medical Oncology $3,051
Dr. Coty Ho, M.d, M.D
Medical Oncology — Payments: $2,498
Medical Oncology $2,498
Lawrence Leichman, M.d, M.D
Medical Oncology — Payments: $30.96
Medical Oncology $30.96